Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013)
Tenax Therapeutics (TENX) posted quarterly Asset Utilization Ratio of 0.38 for Q2 2013, up 427.73% year-over-year from 0.07 in Q2 2012, and up 14.04% on a QoQ basis from 0.34 in Q1 2013.
Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013) Analysis & Trends
Tenax Therapeutics has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.38 in Q2 2013.
- Asset Utilization Ratio for Q2 2013 came in at 0.38, up 427.73% year-over-year; the trailing twelve-month figure through Apr 2013 was 0.38 (up 427.73% YoY), and the FY2013 annual result was 0.33, up 215.83% from the prior year.
- Asset Utilization Ratio rose to 0.38 in Q2 2013, from 0.34 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.38 in Q2 2013 and troughed at 0.03 in Q3 2011.
- A 3-year average of 0.16 and a median of 0.1 in 2012 frame the typical range for Asset Utilization Ratio.
- The largest YoY upside for Asset Utilization Ratio was 567.51% in 2012 against a maximum downside of 387.71% in 2012.
- A 3-year view of Asset Utilization Ratio shows it stood at 0.04 in 2011, then soared by 567.51% to 0.24 in 2012, then surged by 60.99% to 0.38 in 2013.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.38 in Q2 2013, 0.34 in Q1 2013, and 0.24 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.13 |
| 10 | Tenax Therapeutics | 80.05 Mn | 80.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 0.36 |
| Jan 31, 2013 | 0.33 |
| Oct 31, 2012 | 0.23 |
| Jul 31, 2012 | 0.12 |
| Apr 30, 2012 | 0.06 |
| Jan 31, 2012 | 0.05 |
| Oct 31, 2011 | 0.02 |
| Jul 31, 2011 | 0.02 |